XML 38 R26.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Reverse Merger - Additional Information (Detail) $ / shares in Units, $ in Thousands |  |  | 9 Months Ended |
--- | --- | --- | --- | ---
Aug. 17, 2017 USD ($) | Aug. 01, 2017 Right $ / shares shares | Sep. 30, 2017 USD ($) shares | Dec. 31, 2016 shares
Business Acquisition [Line Items] |  |  |  |
Common stock, shares outstanding | shares |  |  | 11,482,845 | 21,230
Contingent value rights recovery | $ |  |  | $ 200 |
OncoGenex Pharmaceuticals, Inc [Member] |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Reverse stock split ratio |  | 0.0909 |  |
Share price |  | $ 4.62 |  |
Common stock, shares outstanding | shares |  | 2,736,703 |  |
Number of contingent value rights to be issued for each share of common stock outstanding | Right |  | 1 |  |
Contingent value rights recovery | $ | $ 200 |  |  |
OncoGenex Pharmaceuticals, Inc [Member] | Contingent Value Rights [Member] |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Combined company acquisition period results |  | 5 years |  |
Aggregate consideration distributed to the holders, consideration received percent |  | 80.00% |  |
OncoGenex Pharmaceuticals, Inc [Member] | Warrant [Member] |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Share price |  | $ 4.62 |  |
OncoGenex Pharmaceuticals, Inc [Member] | Warrant [Member] | Minimum [Member] |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Volatility rate |  | 90.33% |  |
Risk-free interest rate |  | 1.32% |  |
Expected lives |  | 1 year 10 months 28 days |  |
OncoGenex Pharmaceuticals, Inc [Member] | Warrant [Member] | Maximum [Member] |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Volatility rate |  | 106.08% |  |
Risk-free interest rate |  | 1.53% |  |
Expected lives |  | 3 years 2 months 27 days |  |
OncoGenex Pharmaceuticals, Inc [Member] | Stock Options [Member] |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Share price |  | $ 4.62 |  |
OncoGenex Pharmaceuticals, Inc [Member] | Stock Options [Member] | Minimum [Member] |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Volatility rate |  | 97.23% |  |
Risk-free interest rate |  | 1.31% |  |
Expected lives |  | 1 year 9 months 25 days |  |
OncoGenex Pharmaceuticals, Inc [Member] | Stock Options [Member] | Maximum [Member] |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Volatility rate |  | 106.63% |  |
Risk-free interest rate |  | 1.54% |  |
Expected lives |  | 3 years 3 months 22 days |  |

X
- Definition Business combination contingent consideration arrangements, percentage payable to consideration rights holders. + References No definition available. + Details
Name: | achv_BusinessCombinationContingentConsiderationArrangementsPercentagePayableToConsiderationRightsHolders
Namespace Prefix: | achv_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contingent value rights liability recovery. + References No definition available. + Details
Name: | achv_ContingentValueRightsLiabilityRecovery
Namespace Prefix: | achv_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of contingent value rights to be issued for each share of common stock outstanding. + References No definition available. + Details
Name: | achv_NumberOfContingentValueRightsToBeIssuedForEachShareOfCommonStockOutstanding
Namespace Prefix: | achv_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period when results of operations of the acquired entity are included in the income statement of the combined entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionPeriodResultsIncludedInCombinedEntity1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644 + Details
Name: | us-gaap_CommonStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssumptionsExpectedTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssumptionsExpectedVolatilityRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Risk-free interest rate assumption used in valuing an instrument. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssumptionsRiskFreeInterestRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770 + Details
Name: | us-gaap_StockholdersEquityNoteStockSplitConversionRatio1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=achv_OncoGenexPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=achv_ContingentValueRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=achv_WarrantLiabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |